Plain-English translation of NCT01915225 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Colorectal Neoplasms research guide →This is a tissue collection study run by the National Cancer Institute. If you're having surgery or a biopsy for a solid tumor (like colorectal, stomach, bile duct, or pancreatic cancer), researchers ask to collect small samples of your tumor tissue, blood, and other fluids during your procedure. These samples help scientists discover new ways to treat cancer in the future.
Researchers have made major breakthroughs in understanding how cancer grows at the molecular level, which has led to new targeted treatments. However, they need access to real tumor tissue from patients to identify and test new treatment targets that could help future cancer patients.
You likely qualify if…
You likely don't qualify if…
You would participate as part of your regular cancer surgery or biopsy. During your procedure, the surgical team would collect small samples of your tumor tissue, blood, urine, and possibly other fluids—in addition to the tissue removal that is already part of your treatment. The extra sampling does not add risk to your existing procedure. After surgery, your involvement is complete; there are no additional visits or follow-up requirements for the research study itself.
AI-generated summary from trial data · Aug 2, 2026 · Not medical advice
United States